Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Applied Therapeutics FY EPS $(1.42) Beats $(1.44) Estimate, Sales $9.99M Miss $10.67M Estimate

Author: Benzinga Newsdesk | March 06, 2024 08:21am
Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(1.42) per share which beat the analyst consensus estimate of $(1.44) by 1.39 percent. This is a 34.86 percent increase over losses of $(2.18) per share from the same period last year. The company reported quarterly sales of $9.99 million which missed the analyst consensus estimate of $10.67 million by 6.34 percent.

Posted In: APLT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist